David Usharauli
AeroLeads people directory · profile

David Usharauli Email & Phone Number

Co-Founder and Director at Tregeutix Inc.
Location: Orlando, Florida, United States 6 work roles 2 schools
1 work email found @tregeutix.com LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email d****@tregeutix.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Co-Founder and Director
Location
Orlando, Florida, United States

Who is David Usharauli? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

David Usharauli is listed as Co-Founder and Director at Tregeutix Inc., based in Orlando, Florida, United States. AeroLeads shows a work email signal at tregeutix.com and a matched LinkedIn profile for David Usharauli.

David Usharauli previously worked as Scientist (Contractor), Research and Development at Sanofi Pasteur and Scientist at Sanofi Pasteur. David Usharauli holds Doctor Of Medicine (M.D.), Internal Medicine from Tbilisi State Medical University, Tbilisi, Georgia (Republic Of Georgia).

Company email context

Email format at Tregeutix Inc.

This section adds company-level context without repeating David Usharauli's masked contact details.

{first_initial}{last}@tregeutix.com
86% confidence

AeroLeads found 1 current-domain work email signal for David Usharauli. Compare company email patterns before reaching out.

Profile bio

About David Usharauli

David Usharauli is a Co-Founder and Director at Tregeutix Inc.. He possess expertise in flow cytometry, immunology, in vitro, science, elisa and 20 more skills.

Listed skills include Flow Cytometry, Immunology, In Vitro, Science, and 21 others.

Current workplace

David Usharauli's current company

Company context helps verify the profile and gives searchers a useful next step.

Tregeutix Inc.
Tregeutix Inc.
Co-Founder and Director
AeroLeads page
6 roles

David Usharauli work experience

A career timeline built from the work history available for this profile.

Co-Founder And Director

Current

Us

Tregeutix (pronounced ti·rəˈgyoo·tiks or trəˈgyoo·tiks) is advancing unique, first-in-kind antigen-specific immunotherapeutic approaches by addressing how microbiota derived antigen cross-reactivity maintains full and complete repertoire of Foxp3+ regulatory T cells (Tregs) essential for health.

May 2017 - Present

Scientist (Contractor), Research And Development

Paris, France, Fr

Sanofi Pasteur VaxDesign is a wholly owned subsidiary of Sanofi Pasteur (the vaccines division of Sanofi) developing fully human in vitro immunological testbeds for vaccine and biologics evaluation.

Oct 2014 - Oct 2015

Scientist

Paris, France, Fr

Research Projects• Researched and worked out procedures for establishing in vitro “bone marrow” culture supporting propagation and maintenance of human long-lived plasma cells (LLPCs residing in bone marrow are primary responsible for maintaining protective titre of serum antibodies after vaccination. However, prior attempts to develop fully in vitro system that supports propagation and maintenance of LLPCs has been technically challenging). • Explored ways to optimize human antigen-specific B cell activation assay (as a readout to study vaccine-derived antigen and its adjuvant immunogenicity).• Experimented with B cell receptor associated Syk phosphorylation assay as an immunogenicity readout (Syk tyrosine kinase is a critical component of B cell receptor signaling machinery).• Trained and supervised research associates and technicians in the laboratory techniques and good research practices.

Dec 2012 - Oct 2013

Postdoctoral Associate

Paris, France, Fr

Research Projects• Designed a novel assay that revealed mechanism of immunosuppression by TC-83 vaccine (TC-83 is an experimental live-attenuated vaccine strain of Venezuelan equine encephalitis virus, VEEV. However, in human trials TC-83 vaccine showed unexplained adverse side effects, including immunosuppression. It does not have FDA approval). • Conducted experiments with magnetically purified and EBV-transformed human VH1-69+ B cells specific for Flu stem region (VH1-69+ B cells are source of universal anti-Flu antibodies).• Explored ways to optimize of human naive and memory B cell polyclonal activation assay (high antibody yield would enable to detect antigen-specific immune response after vaccination).• Successfully developed human NK cell mediated antibody-dependent cellular cytotoxicity (ADCC) assay against antigen-transduced targets, such as CD52 (alemtuzumab), Flu HA antigen (some of the immunotherapeutic antibodies target tumor cells via ADCC).

Nov 2010 - Dec 2012

Research Fellow

Rockville, Maryland, Us

Notable AccomplishmentsNational Institute of Allergy and Infectious Disease (NIAID) is one of the 27 Institutes and Centers of the National Institutes of Health (NIH). It conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. • Collaborated with the Rocky Mountain Laboratories (RML), Genomics Unit, to design and conduct a statistically-valid sampling of short-term and long-term stimulated CD8 T effector cells for kinetic gene expression microarray analysis.• Promoted research group's scientific education and encouraged open discussion by introducing novel journal club, Blitz, 30 min presentation, conducting twice a week with the emphasis on studies that showed (a) unexpected finding (b) produced contradictory results to the prevailing dogma (c) provided novel explanations of the known observations.

Jan 2009 - Feb 2010

Visiting Fellow

Rockville, Maryland, Us

Research Projects• Explored mechanisms of mouse CD8 T cell effector differentiation (CD8 T cells primary responsible for elimination of infected cells and tumors).• Experimented with mouse CD4+ Foxp3+ regulatory T cell differentiation (CD4+ Foxp3+ regulatory T cells are special subset of CD4 T cells primary responsible for maintaining tolerance to self-antigens). • Worked out conditions to detect Th1-promoting heterodimeric IL-12p70 cytokine in mouse dendritic cells (IL-12p70 is a major cytokine that drives Th1 and cytotoxic CD8 T cell differentiation and plays crucial role in immunity against intracellular pathogens and tumors). • Initiated development of in vitro mouse neonatal organotypic hippocampal slice / T cell co-culture system (neural-immune interface to study immune response in immunoprivileged sites).

Jan 2004 - Jan 2009
2 education records

David Usharauli education

Doctor Of Medicine (M.D.), Internal Medicine

Tbilisi State Medical University, Tbilisi, Georgia (Republic Of Georgia)

Education record

Studied In The Middle School # 166 And The High School # 60, Tbilisi, Georgia
FAQ

Frequently asked questions about David Usharauli

Quick answers generated from the profile data available on this page.

What company does David Usharauli work for?

David Usharauli works for Tregeutix Inc..

What is David Usharauli's role at Tregeutix Inc.?

David Usharauli is listed as Co-Founder and Director at Tregeutix Inc..

What is David Usharauli's email address?

AeroLeads has found 1 work email signal at @tregeutix.com for David Usharauli at Tregeutix Inc..

Where is David Usharauli based?

David Usharauli is based in Orlando, Florida, United States while working with Tregeutix Inc..

What companies has David Usharauli worked for?

David Usharauli has worked for Tregeutix Inc., Sanofi Pasteur, and National Institute Of Allergy And Infectious Diseases (Niaid).

How can I contact David Usharauli?

You can use AeroLeads to view verified contact signals for David Usharauli at Tregeutix Inc., including work email, phone, and LinkedIn data when available.

What schools did David Usharauli attend?

David Usharauli holds Doctor Of Medicine (M.D.), Internal Medicine from Tbilisi State Medical University, Tbilisi, Georgia (Republic Of Georgia).

What skills is David Usharauli known for?

David Usharauli is listed with skills including Flow Cytometry, Immunology, In Vitro, Science, Elisa, In Vivo, Antibodies, and R&D.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.